Entry - #614886 - PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER); PBD12A - OMIM
# 614886

PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER); PBD12A


Other entities represented in this entry:

PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 14, INCLUDED
CG14, INCLUDED
PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP J, INCLUDED
CGJ, INCLUDED

Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
1q23.2 Peroxisome biogenesis disorder 12A (Zellweger) 614886 AR 3 PEX19 600279
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal recessive
GROWTH
Height
- Short stature (3rd centile)
Weight
- Low weight (3rd centile)
HEAD & NECK
Head
- Small head (3rd centile)
- Hydrocephalus
- Scaphocephaly
Face
- Triangular face
- Prominent premaxilla
- Small receding chin
Ears
- Asymmetric abnormal ears
Eyes
- Epicanthal folds
- Periorbital puffiness
Nose
- Prominent nose
- Broad nasal bridge
CARDIOVASCULAR
Heart
- Systolic murmur
- Patent ductus arteriosus
- Atrial septal defect
- Double outlet right ventricle (DORV)
ABDOMEN
Liver
- Hyperbilirubinemia
- Liver failure
Biliary Tract
- Gallstones
GENITOURINARY
External Genitalia (Male)
- Abnormal male genitals
Kidneys
- Renal tubular defect
SKELETAL
- Dense bones
Skull
- Cranial asymmetry
- Wide anterior fontanel
- Wide posterior fontanel
- Open sagittal metopic sutures
MUSCLE, SOFT TISSUES
- Hypotonia
NEUROLOGIC
Central Nervous System
- Absent Moro reflex
- Absent palmar grasp
- Brisk tendon reflexes
- Epilepsy (resistant to conventional anticonvulsant drugs)
- Global developmental delay
- Cerebral atrophy seen on MRI
- Diffuse demyelination seen on MRI
HEMATOLOGY
- Disseminated coagulopathy
PRENATAL MANIFESTATIONS
Movement
- Reduced fetal movement
Amniotic Fluid
- Diminished amniotic fluid
LABORATORY ABNORMALITIES
- Elevated plasma very long chain fatty acids (VLCFA)
- Complete absence of peroxisomes in fibroblasts
- Deficiency of dihydroxyacetonephosphate acyltransferase (DHAPAT)
- Decreased pristanic acid beta-oxidation
- Decreased phytanic acid alpha-oxidation
MISCELLANEOUS
- Recurrent severe sepsis
- Death by 16 months of age
- Three patients have been reported (last curated January 2017)
MOLECULAR BASIS
- Caused by mutation in the peroxisome biogenesis factor 19 gene (PEX19, 600279.0001)
Peroxisome biogenesis disorder - PS214100 - 27 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p36.32 Peroxisome biogenesis disorder 6B AR 3 614871 PEX10 602859
1p36.32 Peroxisome biogenesis disorder 6A (Zellweger) AR 3 614870 PEX10 602859
1p36.22 Peroxisome biogenesis disorder 13A (Zellweger) AR 3 614887 PEX14 601791
1q21.1 Peroxisome biogenesis disorder 14B AR 3 614920 PEX11B 603867
1q23.2 Peroxisome biogenesis disorder 12A (Zellweger) AR 3 614886 PEX19 600279
2p15 Peroxisome biogenesis disorder 11B AR 3 614885 PEX13 601789
2p15 Peroxisome biogenesis disorder 11A (Zellweger) AR 3 614883 PEX13 601789
6p21.1 Peroxisome biogenesis disorder 4B AD, AR 3 614863 PEX6 601498
6p21.1 Peroxisome biogenesis disorder 4A (Zellweger) AR 3 614862 PEX6 601498
6p21.1 Heimler syndrome 2 AR 3 616617 PEX6 601498
6q23.3 Rhizomelic chondrodysplasia punctata, type 1 AR 3 215100 PEX7 601757
6q23.3 Peroxisome biogenesis disorder 9B AR 3 614879 PEX7 601757
6q24.2 Peroxisome biogenesis disorder 10A (Zellweger) AR 3 614882 PEX3 603164
6q24.2 ?Peroxisome biogenesis disorder 10B AR 3 617370 PEX3 603164
7q21.2 Peroxisome biogenesis disorder 1B (NALD/IRD) AR 3 601539 PEX1 602136
7q21.2 Peroxisome biogenesis disorder 1A (Zellweger) AR 3 214100 PEX1 602136
7q21.2 Heimler syndrome 1 AR 3 234580 PEX1 602136
8q21.13 Peroxisome biogenesis disorder 5A (Zellweger) AR 3 614866 PEX2 170993
8q21.13 Peroxisome biogenesis disorder 5B AR 3 614867 PEX2 170993
11p11.2 Peroxisome biogenesis disorder 8B AR 3 614877 PEX16 603360
11p11.2 Peroxisome biogenesis disorder 8A (Zellweger) AR 3 614876 PEX16 603360
12p13.31 Peroxisome biogenesis disorder 2A (Zellweger) AR 3 214110 PEX5 600414
12p13.31 Peroxisome biogenesis disorder 2B AR 3 202370 PEX5 600414
17q12 Peroxisome biogenesis disorder 3A (Zellweger) AR 3 614859 PEX12 601758
17q12 Peroxisome biogenesis disorder 3B AR 3 266510 PEX12 601758
22q11.21 Peroxisome biogenesis disorder 7A (Zellweger) AR 3 614872 PEX26 608666
22q11.21 Peroxisome biogenesis disorder 7B AR 3 614873 PEX26 608666

TEXT

A number sign (#) is used with this entry because this form of Zellweger syndrome (PBD12A) is caused by homozygous mutation in the PEX19 gene (600279) on chromosome 1q23.


Description

Zellweger syndrome (ZS) is an autosomal recessive multiple congenital anomaly syndrome resulting from disordered peroxisome biogenesis. Affected children present in the newborn period with profound hypotonia, seizures, and inability to feed. Characteristic craniofacial anomalies, eye abnormalities, neuronal migration defects, hepatomegaly, and chondrodysplasia punctata are present. Children with this condition do not show any significant development and usually die in the first year of life (summary by Steinberg et al., 2006).

For a complete phenotypic description and a discussion of genetic heterogeneity of Zellweger syndrome, see 214100.

Individuals with PBDs of complementation group 14 (CG14, equivalent to CGJ) have mutations in the PEX19 gene. For information on the history of PBD complementation groups, see 214100.


Clinical Features

Mohamed et al. (2010) studied a female infant, born of consanguineous Saudi parents, with Zellweger syndrome, The patient had neonatal hypotonia, poor growth, and subtle dysmorphic features, including cranial asymmetry, triangular face, low hairline, open fontanels, and broad nasal bridge. Laboratory studies showed elevated liver enzymes, hyperbilirubinemia, and a very long chain fatty acid (VLCFA) profile consistent with a PBD. Brain imaging showed cerebral atrophy, cortical changes, and diffuse demyelination. There was a complete absence of peroxisomes in patient fibroblasts. The patient had a severe clinical course, complicated by global developmental delay, refractory seizures, renal tubular defect, multiple gallstones, and recurrent hospitalizations. She died of sepsis at age 16 months.


Molecular Genetics

Kinoshita et al. (1998) identified complementation group J (CGJ) from patients with Zellweger syndrome. Two Chinese hamster ovary cell mutants were also found to belong to this group. In no CGJ mutant cell were peroxisomal ghosts found.

Matsuzono et al. (1999) identified a homozygous 1-bp insertion in the PEX19 gene (600279.0001) in a patient with Zellweger syndrome of complementation group J.

Mohamed et al. (2010) identified a homozygous frameshift mutation in the PEX19 gene (600279.0002) in a female infant with Zellweger syndrome.


REFERENCES

  1. Kinoshita, N., Ghaedi, K., Shimozawa, N., Wanders, R. J. A., Matsuzono, Y., Imanaka, T., Okumoto, K., Suzuki, Y., Kondo, N., Fujiki, Y. Newly identified Chinese hamster ovary cell mutants are defective in biogenesis of peroxisomal membrane vesicles (peroxisomal ghosts), representing a novel complementation group in mammals J. Biol. Chem. 273: 24122-24130, 1998. [PubMed: 9727033, related citations] [Full Text]

  2. Matsuzono, Y., Kinoshita, N., Tamura, S., Shimozawa, N., Hamasaki, M., Ghaedi, K., Wanders, R. J. A., Suzuki, Y., Kondo, N., Fujiki, Y. Human PEX19: cDNA cloning by functional complementation, mutation analysis in a patient with Zellweger syndrome, and potential role in peroxisomal membrane assembly. Proc. Nat. Acad. Sci. 96: 2116-2121, 1999. [PubMed: 10051604, images, related citations] [Full Text]

  3. Mohamed, S., El-Meleagy, E., Nasr, A., Ebberink, M. S., Wanders, R. J. A., Waterham, H. R. A mutation in PEX19 causes a severe clinical phenotype in a patient with peroxisomal biogenesis disorder. Am. J. Med. Genet. 152A: 2318-2321, 2010. [PubMed: 20683989, related citations] [Full Text]

  4. Steinberg, S. J., Dodt, G., Raymond, G. V., Braverman, N. E., Moser, A. B., Moser, H. W. Peroxisome biogenesis disorders. Biochim. Biophys. Acta 1763: 1733-1748, 2006. [PubMed: 17055079, related citations] [Full Text]


Creation Date:
Anne M. Stumpf : 10/17/2012
carol : 01/26/2017
alopez : 10/25/2012
carol : 10/25/2012
alopez : 10/24/2012

# 614886

PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER); PBD12A


Other entities represented in this entry:

PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 14, INCLUDED
CG14, INCLUDED
PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP J, INCLUDED
CGJ, INCLUDED

ORPHA: 79189, 912;   DO: 0080486;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
1q23.2 Peroxisome biogenesis disorder 12A (Zellweger) 614886 Autosomal recessive 3 PEX19 600279

TEXT

A number sign (#) is used with this entry because this form of Zellweger syndrome (PBD12A) is caused by homozygous mutation in the PEX19 gene (600279) on chromosome 1q23.


Description

Zellweger syndrome (ZS) is an autosomal recessive multiple congenital anomaly syndrome resulting from disordered peroxisome biogenesis. Affected children present in the newborn period with profound hypotonia, seizures, and inability to feed. Characteristic craniofacial anomalies, eye abnormalities, neuronal migration defects, hepatomegaly, and chondrodysplasia punctata are present. Children with this condition do not show any significant development and usually die in the first year of life (summary by Steinberg et al., 2006).

For a complete phenotypic description and a discussion of genetic heterogeneity of Zellweger syndrome, see 214100.

Individuals with PBDs of complementation group 14 (CG14, equivalent to CGJ) have mutations in the PEX19 gene. For information on the history of PBD complementation groups, see 214100.


Clinical Features

Mohamed et al. (2010) studied a female infant, born of consanguineous Saudi parents, with Zellweger syndrome, The patient had neonatal hypotonia, poor growth, and subtle dysmorphic features, including cranial asymmetry, triangular face, low hairline, open fontanels, and broad nasal bridge. Laboratory studies showed elevated liver enzymes, hyperbilirubinemia, and a very long chain fatty acid (VLCFA) profile consistent with a PBD. Brain imaging showed cerebral atrophy, cortical changes, and diffuse demyelination. There was a complete absence of peroxisomes in patient fibroblasts. The patient had a severe clinical course, complicated by global developmental delay, refractory seizures, renal tubular defect, multiple gallstones, and recurrent hospitalizations. She died of sepsis at age 16 months.


Molecular Genetics

Kinoshita et al. (1998) identified complementation group J (CGJ) from patients with Zellweger syndrome. Two Chinese hamster ovary cell mutants were also found to belong to this group. In no CGJ mutant cell were peroxisomal ghosts found.

Matsuzono et al. (1999) identified a homozygous 1-bp insertion in the PEX19 gene (600279.0001) in a patient with Zellweger syndrome of complementation group J.

Mohamed et al. (2010) identified a homozygous frameshift mutation in the PEX19 gene (600279.0002) in a female infant with Zellweger syndrome.


REFERENCES

  1. Kinoshita, N., Ghaedi, K., Shimozawa, N., Wanders, R. J. A., Matsuzono, Y., Imanaka, T., Okumoto, K., Suzuki, Y., Kondo, N., Fujiki, Y. Newly identified Chinese hamster ovary cell mutants are defective in biogenesis of peroxisomal membrane vesicles (peroxisomal ghosts), representing a novel complementation group in mammals J. Biol. Chem. 273: 24122-24130, 1998. [PubMed: 9727033] [Full Text: https://doi.org/10.1074/jbc.273.37.24122]

  2. Matsuzono, Y., Kinoshita, N., Tamura, S., Shimozawa, N., Hamasaki, M., Ghaedi, K., Wanders, R. J. A., Suzuki, Y., Kondo, N., Fujiki, Y. Human PEX19: cDNA cloning by functional complementation, mutation analysis in a patient with Zellweger syndrome, and potential role in peroxisomal membrane assembly. Proc. Nat. Acad. Sci. 96: 2116-2121, 1999. [PubMed: 10051604] [Full Text: https://doi.org/10.1073/pnas.96.5.2116]

  3. Mohamed, S., El-Meleagy, E., Nasr, A., Ebberink, M. S., Wanders, R. J. A., Waterham, H. R. A mutation in PEX19 causes a severe clinical phenotype in a patient with peroxisomal biogenesis disorder. Am. J. Med. Genet. 152A: 2318-2321, 2010. [PubMed: 20683989] [Full Text: https://doi.org/10.1002/ajmg.a.33560]

  4. Steinberg, S. J., Dodt, G., Raymond, G. V., Braverman, N. E., Moser, A. B., Moser, H. W. Peroxisome biogenesis disorders. Biochim. Biophys. Acta 1763: 1733-1748, 2006. [PubMed: 17055079] [Full Text: https://doi.org/10.1016/j.bbamcr.2006.09.010]


Creation Date:
Anne M. Stumpf : 10/17/2012

Edit History:
carol : 01/26/2017
alopez : 10/25/2012
carol : 10/25/2012
alopez : 10/24/2012